ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (6): 521-527.DOI: 10.3969/j.issn.1006-298X.2023.06.004

• • 上一篇    下一篇

辅酶Q8B基因缺陷相关肾病的临床病理和基因变异特征

  

  • 出版日期:2023-12-28 发布日期:2023-12-22

Clinicopathological and genetic features of COQ8B nephropathy

  • Online:2023-12-28 Published:2023-12-22

摘要: 目的:探讨辅酶Q8B(COQ8B)基因缺陷相关肾病的临床病理及基因变异特征。
方法:回顾分析国家肾脏疾病临床医学研究中心经基因检测诊断COQ8B基因缺陷相关肾病患者的临床资料和家系基因检测结果,总结其临床特点、治疗及预后。
结果:共纳入9例携带COQ8B双等位基因突变的患者,其中2例纯合突变,7例复合杂合突变,所有患者遗传模式符合常染色体隐性遗传特点。基因分析检测到COQ8B基因的7个突变(NM_024876 c.748G>C、c.737G>A、c.1093C>G、c.532C>T、c.449G>A、c.1468C>T、c.1465C>T),其中c.737G>A错义突变为本组患者的热点突变。患者临床表型多局限于肾脏,7例患者以非肾病范围蛋白尿起病,2例表现为肾病综合征,中位起病年龄17岁。5例患者进展至终末期肾病(ESKD),ESKD中位年龄19岁。5例患者影像学提示肾髓质钙化。6例行肾活检的患者中4例表现为局灶节段性肾小球硬化,电镜下可见足细胞和肾小管上皮细胞内线粒体异常。患者对免疫抑制剂治疗无反应。有2例患者采用辅酶Q10治疗,效果欠佳,可能与治疗开始时机较晚有关。
结论:COQ8B基因缺陷相关肾病以青少年期起病的蛋白尿为主要表现,肾脏病理以局灶节段性肾小球硬化为主。肾髓质钙化和电镜下线粒体异常可作为此类患者行基因检测的临床线索。早期基因诊断并及时补充辅酶Q10治疗可能有助于改善患者预后。


关键词: 辅酶Q8B基因, 肾病综合征, 局灶节段性肾小球硬化, 肾髓质钙化

Abstract: Objective:To investigate the clinical and genetic features of patients with COQ8B nephropathy.
Methodology:We retrospectively analyzed the clinical and pathological manifestations, treatment and prognosis in patients diagnosed with COQ8B nephropathy by genetic test.
Results:A total of nine patients with biallelic mutations of COQ8B were included, among which two patients carried homozygous mutation, and seven patients carried compound heterozygous mutation. The genetic pattern of all patients was consistent with autosomal recessive inheritance pattern. Mutation analysis revealed seven sequence variants in COQ8B (NM_024876 c.748G>C、c.737G>A、c.1093C>G、c.532C>T、c.449G>A、c.1468C>T、c.1465C>T), among which c.737G>A missense mutation is a hotspot mutation in these patients. Patients showed a largely renal-limited phenotype. Of the nine patients, seven started with non-nephrotic proteinuria, and two presented with nephrotic syndrome. The median age at onset was 17 years. Five patients progressed to end-stage kidney disease with a median age at 19 years. Medullary nephrocalcinosis was detected in five patients. Six patients underwent renal biopsy, among which four showed focal segmental glomerulosclerosis. Electron microscopy examination revealed mitochondrial abnormalities. Patients did not respond to immunosuppressive therapy. Treatment with coenzyme Q10 (COQ10) in two patients didnt result in a significant clinical improvement, which may be due to the late initiation of treatment.
Conclusion:COQ8B mutation can lead to autosomal recessive genetic disease manifested by adolescent-onset proteinuria. The main pathological feature is focal segmental glomerulosclerosis. Mitochondrial abnormalities under electron microscope and medullary nephrocalcinosis may be clinical indicators for genetic test. Early genetic diagnosis and COQ10 supplementation can improve prognosis in these patients.


Key words: COQ8B, nephrotic syndrome, focal segmental glomerulosclerosis, medullary nephrocalcinosis